Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search
Fullscreen

For citation:


Zyryanov S.K., Diyakov I.N. Pharmacoeconomic efficacy of atesolizumab compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2020;13(1):5-12. (In Russ.) https://doi.org/10.17749/2070-4909.2020.13.1.5-12

Views: 316


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)